Abstract: A method for detecting concentration of iodine in water samples. An arsenite-containing test solution, a tetravalent cerium ion-containing test solution and a series of iodine-containing standard solutions are prepared. The standard solutions are added to primary wells of a microplate, respectively. A water sample is added to a secondary well. The arsenite-containing test solution and the tetravalent cerium ion-containing test solution are sequentially added to the primary wells and the secondary well. Reaction mixture in each well is reacted and then measured for absorbance by a detector. A standard curve is plotted according to the absorbance of each primary well and a concentration of each iodine-containing standard solution. The absorbance of the sample is plugged into the standard curve to obtain an iodine concentration in the sample.

Abstract: A method for detecting concentration of iodine in water samples. An arsenite-containing test solution, a tetravalent cerium ion-containing test solution and a series of iodine-containing standard solutions are prepared. The standard solutions are added to primary wells of a microplate, respectively. A water sample is added to a secondary well. The arsenite-containing test solution and the tetravalent cerium ion-containing test solution are sequentially added to the primary wells and the secondary well. Reaction mixture in each well is reacted and then measured for absorbance by a detector. A standard curve is plotted according to the absorbance of each primary well and a concentration of each iodine-containing standard solution. The absorbance of the sample is plugged into the standard curve to obtain an iodine concentration in the sample.

Abstract: The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof. The compounds of formula I are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

Abstract: The present invention relates to a compound represented by formula (I): and pharmaceutically acceptable salts thereof. The compounds of formula I are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-coupled receptor 40. The compounds of the present invention may be useful in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.